Viewing nowYespra Tablet 20mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
You and Life Science Co., Ltd.

MFDS item code 201908380 · Approved 2019.12.12
Management of acid-related disorders (such as reflux disease), ulcers, and gastrointestinal symptoms; treatment of Helicobacter pylori
This medication is used for the treatment of gastroesophageal reflux disease, particularly erosive esophagitis, and for maintenance therapy to prevent the recurrence of esophagitis. It also helps in the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers related to antibiotic therapy for the eradication of Helicobacter pylori. It is effective in treating upper gastrointestinal symptoms associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) and in the treatment and prevention of gastric ulcers. It is used for the treatment of Zollinger-Ellison syndrome and for maintenance therapy after the prevention of rebleeding due to gastric or duodenal ulcers. Thus, it improves symptom relief and prevention of recurrence for various gastrointestinal diseases.
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent symptoms may be controlled by taking 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug use - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. 6) Maintenance therapy after initiation of intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks after initiating intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers. 4. Renal impairment: No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. 5. Hepatic impairment: No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed 20 mg of this medicine. 6. Elderly patients: No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent symptoms may be controlled by taking 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years of age: There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be used in patients with allergies to specific components or who have had hypersensitivity reactions. Additionally, it is unsafe for patients taking certain antibiotics or antivirals, women with a history of myocardial infarction, or those who are breastfeeding. Patients allergic to the dye Yellow No. 4 should use this medication cautiously. While using this medication, caution is needed as blood-related adverse reactions such as leukopenia, thrombocytopenia, and hypomagnesemia may occur. Gastrointestinal symptoms such as headache, dizziness, abdominal pain, diarrhea, and vomiting may also occur, so if symptoms are severe, consultation with a physician is recommended. This medication suppresses gastric acid secretion, which can increase bacterial growth in the stomach, potentially raising the risk of infection. Long-term use may increase the risk of fractures, so attention to bone health is necessary. Regular blood tests and magnesium level checks are recommended for those taking this medication long-term. Due to potential interactions with other medications, especially anticoagulants, anticonvulsants, and antidepressants, it is important to inform healthcare professionals and monitor the condition closely. Caution is needed when using this medication during pregnancy, and it is safest not to take this medication while breastfeeding. In case of overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms. Keep out of reach of children and store in the original packaging to maintain quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, perception abnormalities, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, severe cutaneous adverse reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reactions with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reactions, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, worsening of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatologic polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, abnormal olfaction, taste loss, gustatory distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to store at room temperature between 1°C and 30°C.
Pink round film-coated tablet
28 tablets/PTP[((14 tablets/PTP) X 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
You and Life Science Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.